NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared Diagnostic Hybrids' respiratory viral identification kit for use in the US, the company said Tuesday.

Diagnostic Hybrids, which is based in Athens, Ohio, said that the FDA has cleared its D3 Fastpoint L-DFA RSV/MPV Identification kit.

The kit allows for the identification of respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in less than 25 minutes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.